MedTech R&D: Accelerating Cancer Detection with Computer Vision
Back to Stories
HealthcareIT Staff Augmentation

MedTech R&D: Accelerating Cancer Detection with Computer Vision

Augmenting a research team to bring a life-saving device to FDA trials.

30s
Speed
Processing time (down from 5m)
99.2% Sensitivity, 97% Specificity
Diagnostic Accuracy
False-positive rate cut enough to clear the FDA review bottleneck
Cleared
Approval
Passed FDA 510(k)

The Challenge

M.V Labs had a brilliant algorithm but slow execution. Their model took 5 minutes to process a scan, making it unusable in clinical workflows. They lacked engineers who understood both Deep Learning and High-Performance Computing (C++/CUDA).

Inference time too slow for real-time use.
False positive rate delaying FDA submission.
Lack of expertise in DICOM standard integration.

The Solution

M.V Labs' research leads set the target: cut inference time and the false-positive rate without sacrificing accuracy. GTEMAS augmented their R&D team with 2 Computer Vision Engineers and 1 MLOps specialist to execute it. Working within the existing research group, our engineers rewrote the inference pipeline from Python to optimized C++ using TensorRT, and redesigned the model as a 3D U-Net that considered volumetric context instead of scanning slice by slice, which cut the false positives that had been stalling the FDA submission.

Architectural Strategy

Hybrid cloud architecture processing DICOM images on edge servers using NVIDIA Triton Inference Server.

Impact & Achievements

The speed optimization was the key to commercial viability. The product is now deployed in 40+ hospitals across the EU.

30s
Speed

Processing time (down from 5m)

99.2% Sensitivity, 97% Specificity
Diagnostic Accuracy

False-positive rate cut enough to clear the FDA review bottleneck

Cleared
Approval

Passed FDA 510(k)

Ready to write your success story?

Partner with Global Tech Masters to build scalable, high-performance digital products.